Chronic Kidney Disease-Pandora’s Infectious Box !!!
Abstract
No abstract
References
1. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998;32(Suppl 3):S112-S119.
2. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758-1764.
3. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits- Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly. Kidney Int. 2005;67:1216-1233.
4. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int. 1998;54:236-244.
5. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I: Disturbances of acquired immunity in hemodialysis patients.Semin Dial. 2007;20:440-451
6. Meuer SC, Hauer M, Kurz P, Meyer zum Buschenfelde KH, Kohler H: Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest. 1987;80:743-749.
7. Stachowski J, Pollok M, Burrichter H, Spithaler C, Baldamus CA: Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number. Nephron. 1993;64:369-375.
8. Girndt M, Sester M, Sester U, Kaul H, Kohler H: Defective expression of B7–2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59:1382-1389.
2. Sarnak MJ, Jaber BL: Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int. 2000;58:1758-1764.
3. Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits- Filho R, Riella M, Heimburger O, Cederholm T, Girndt M: IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia–the good, the bad, and the ugly. Kidney Int. 2005;67:1216-1233.
4. Kimmel PL, Phillips TM, Simmens SJ, Peterson RA, Weihs KL, Alleyne S, Cruz I, Yanovski JA, Veis JH: Immunologic function and survival in hemodialysis patients. Kidney Int. 1998;54:236-244.
5. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I: Disturbances of acquired immunity in hemodialysis patients.Semin Dial. 2007;20:440-451
6. Meuer SC, Hauer M, Kurz P, Meyer zum Buschenfelde KH, Kohler H: Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses. J Clin Invest. 1987;80:743-749.
7. Stachowski J, Pollok M, Burrichter H, Spithaler C, Baldamus CA: Signalling via the TCR/CD3 antigen receptor complex in uremia is limited by the receptors number. Nephron. 1993;64:369-375.
8. Girndt M, Sester M, Sester U, Kaul H, Kohler H: Defective expression of B7–2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defect. Kidney Int. 2001;59:1382-1389.
Published
2019-08-27
How to Cite
Zaheer Amin Virani, Kohli J, Rajput P, Shah B V, Murthy A. (2019). Chronic Kidney Disease-Pandora’s Infectious Box !!!. The Indian Practitioner, 68(4), 45-47. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/650
Section
Case Reports
